molecular basis of blood clotting disorders Flashcards
describe haemophilia
failure to clot = haemorrhage
mutations in coagulation factors (haemophilia A + B)
platelet disorders (VW disease)
collagen abnormalities
describe thrombophilia
excessive clotting = thrombosis
- inherited = mutations in coagulation factors
- acquired = malignancy increases clotting factors
what is disseminated intravascular coagulation
whole body clots = infection
depletion of clotting factors and platelets lead to bleeding
list the 2 bleeding disorders
haemophilia A and B = swelling and bruising
von willerband disease = inherited. affects mucous membranes/ bleeding in gums
describe excessive clotting
factor V5 leiden mutation = resistance to ADC, not inactivated. increases risk of DVT
antithrombin deficiency = thrombin, Ixa, Fxa, not inactivated. increases risk of DVT
protein c and s deficiency = increase risk of DVT
what is virchow’s triad
alterations in constituents of blood
changes In normal blood flow
damage to endothelial layer
- stasis
- hyper coagulability
- vessel wall injury
symptoms of deep vein thrombosis
swelling skin changes superficial venous distension increased skin temp skin discolouration risk of pulmonary embolism
describe disseminated intravascular coagulation
clotting and bleeding
in sepsis.
depletion of clotting factors and platelets = bleeding
how do anticoagulants prevent more clots
e.g warfarin, heparin, direct oral anticoagulants
whereas,
thrombolytics/fibrinolysis reverse this
e.g plasminogen activators, tPA, streptokinase
management of VTE: pre and post treatment
pre:
- clotting screen
- full blood count
- renal screen
- liver function test
post:
- DVT = anticoagulant
PE = thrombolysis
alteplase, streptokinase
followed by anticoagulant to prevent recurrence
bleeding complications can occur from anticoagulants